Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1152-1156

  Serkies, K ^a   Jassem, J ^a   Dziadziuszko, R ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cervical cancer; Chemotherapy; Recurrence

Indexed keywords

CISPLATIN; IFOSFAMIDE; MITOMYCIN C;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PELVIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CARCINOMA, ADENOSQUAMOUS; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG EVALUATION; FEMALE; HUMANS; IFOSFAMIDE; LEUKOPENIA; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 33745073471     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00548.x     Document Type: Article

References (22)

1. Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994 21: 54 62.
2. Thigpen JT Blessing JA DiSaia PJ et al. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989 32: 198 202.
3. Sutton GP Blessing JA McGuire WP et al. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1993 168: 805 7.
4. Omura GA Blessing JA Vaccarello L et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997 15: 165 71.
5. Baker LH Opipari MI Wilson H et al. Mitomycin C, vincristine and bleomycin therapy for advanced cervical cancer. Obstet Gynecol 1978 52: 146 50.
6. Cullen MH Jashi R Chetiyawardana AD et al. Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer: treatment good enough to compare. Br J Cancer 1988 58: 359 61.
7. Szanto I Soedirman JR Szantho A et al. Mitomycin C, ifosfamide, cisplatin (MIC) in patients with advanced or recurrent cervical cancer [abstract]. Ann Oncol 1998 9 ( Suppl. 4 71.
8. Hryniuk WM Goodyear M. The calculation of received dose intensity. J Clin Oncol 1990 8: 1935 7.
9. Trudeau M Seymour R Stanimir G et al. A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix. Int J Gynecol Cancer 2000 10: 207 11.
10. Bloss JD Blessing JA Behrens BC et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2002 20: 1832 7.
11. Fanning J Lado Ch Hilgers RD. Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer. Gynecol Oncol 1995 56: 235 8.
12. Kumar L Bhargava VL. Chemotherapy in recurrent and advanced cervical cancer. Gynecol Oncol 1991 12: 55 9.
13. Murad AM Triginnelli SA Ribalta CL. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer. J Clin Oncol 1994 12: 55 9.
14. Potter ME Hatch KD Potter MY et al. Factors influenced response of recurrent squamous cell carcinoma of the cervix with cisplatin. Cancer 1989 63: 1283 6.
15. Burnutt AF Roman LD Garcia AA et al. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000 76: 63 6.
16. Rose PG Blessing JA Gershenson DM et al. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1999 17: 2676 80.
17. Eralp Y Saip P Sakar B et al. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix. Int J Gynecol Cancer 2003 13: 497 504.
18. Brader KR Morris M Levenback C et al. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 1998 16: 1879 84.
19. Pignata S Silvestro G Ferrari E et al. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 1999 17: 756 60.
20. Papadimitriou CA Dimopoulos MA Giannakoulis N et al. A phase II trial of methotrexate, vinblastin, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix. Cancer 1997 79: 2391 5.
21. Chitapanarux I Tonusin A Sukthomya V et al. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer. Gynecol Oncol 2003 89: 402 7.
22. Fiorica J Holloway R Ndubisi B et al. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinoma of the cervix. Gynecol Oncol 2002 85: 89 94.